Alcon Breaks Ground On Singapore Plant To Make Eye-care Drugs
This article was originally published in PharmAsia News
Executive Summary
Alcon, a Switzerland-based maker of eye-care products, has begun construction of its first Asian production plant in Singapore. Alcon said the plant was needed because of the company's growth in Asia, for making drugs to treat eye disorders such as glaucoma. Alcon said it expects to complete construction in 2012, when it expects to create 150 new jobs. Novartis AG, another Swiss drug maker, plans to buy a 77 percent interest in Alcon, beyond its existing 25 percent stake. (Click here for more